Characterisation of chromatin modifiers in endometrial cancer

Characterisation of chromatin modifiers in endometrial cancer

<p>Chromatin organization is a critical regulator of gene expression and cell phenotype, and is frequently dysregulated in cancer. Endometrial cancer (EC) is the most common gynecological malignancy, and casues significant morbidity and mortality. EC is notable for recurrent alterations in chr...

Bibliografske podrobnosti
Glavni avtor:	Kedzierska, KZ
Drugi avtorji:	Church, D
Format:	Thesis
Jezik:	English
Izdano:	2024
Teme:	Cancer

Podobne knjige/članki

Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells
od: Dore M, et al.
Izdano: (2021-10-01)

Prognostic Significance of Dysregulated Epigenomic and Chromatin Modifiers in Cervical Cancer
od: Aswathy Mary Paul, et al.
Izdano: (2021-10-01)

A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients
od: Zesi Liu, et al.
Izdano: (2022-10-01)

Characterising ISWI chromatin remodeler in Trypanosoma cruzi
od: Yirys Díaz-Olmos, et al.

Druggable genetic targets in endometrial cancer✰,✰✰
od: Steven Lehrer, et al.
Izdano: (2022-01-01)

The treatment of special types of endometrial cancer
od: Meng Zhang, et al.
Izdano: (2022-08-01)

Endometrial Atypical Hyperplasia and Risk of Endometrial Cancer
od: An-Ju Chou, et al.
Izdano: (2024-11-01)

Genomic profiling of endometrial cancer and relationship with volume of endometrial cancer disease spread
od: Stephanie A. Sullivan, et al.
Izdano: (2021-05-01)

Importance of the endometrial immune environment in endometrial cancer and associated therapies
od: Hannah van der Woude, et al.
Izdano: (2022-08-01)

How Immunotherapy Modified the Therapeutic Scenario of Endometrial Cancer: A Systematic Review
od: Brigida Anna Maiorano, et al.
Izdano: (2022-04-01)

Chromatin structure in cancer
od: Meng Wang, et al.
Izdano: (2022-07-01)

Robotics in Endometrial Cancer Care
od: Joseph Ng
Izdano: (2013-11-01)

The modern management of endometrial cancer
od: Catherine M. Holland, et al.
Izdano: (2011-12-01)

The modern management of endometrial cancer
od: Catherine M. Holland, et al.
Izdano: (2011-12-01)

GENETIC ASPECTS OF ENDOMETRIAL CANCER
od: V. A. Pushkarev, et al.
Izdano: (2014-09-01)

The Role of Selected Adipocytokines in Ovarian Cancer and Endometrial Cancer
od: Sebastian Stępień, et al.
Izdano: (2023-04-01)

Racioethnic Disparities in Endometrial Cancer Outcomes
od: Ojone Illah, et al.
Izdano: (2024-02-01)

TRENDS OF ENDOMETRIAL CANCER IN CENTRAL INDIA: AN INSTITUTIONAL REVIEWTrends of Endometrial Cancer in Central India: An Institutional Review
od: Dhruv G Patel, et al.
Izdano: (2020-06-01)

Management of inoperable endometrial cancer
od: Supakorn Pitakkarnkul, et al.
Izdano: (2022-07-01)

The Roles of Endoscopy in Endometrial Cancer
od: Chyi-Long Lee, et al.
Izdano: (2008-12-01)

PREDICTION ENDOMETRIAL CANCER IN WOMEN WITH ENDOMETRIAL HYPERPLASTIC PROCESSES IN PREMENOPAUSAL
od: A. L. Unanyan, et al.
Izdano: (2016-09-01)

The Exploration of Chemokines Importance in the Pathogenesis and Development of Endometrial Cancer
od: Jakub Dobroch, et al.
Izdano: (2022-03-01)

KLHL14, an ovarian and endometrial-specific gene, is over-expressed in ovarian and endometrial cancer
od: Mi Han, et al.
Izdano: (2020-01-01)

Assessment of Preoperative Endometrial Histopathological Sampling as a Predictor of Final Surgical Pathology in Endometrial Cancer
od: Mario Augusto Silveira Bueno Piotto, et al.

Telomeres and telomerase in endometrial cancer and hyperplasia
od: Anna Pańczyszyn, et al.
Izdano: (2024-03-01)

Epidemiology of Endometrial Cancer in North of Iran
od: Shahla Yazdani, et al.
Izdano: (2017-01-01)

The significance of markers in the diagnosis of endometrial cancer
od: Monika M. Żyła, et al.
Izdano: (2016-11-01)

Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancer
od: Amritha Sreekumar, et al.
Izdano: (2023-01-01)

Preoperative Haematologic Markers for the Differentiation of Endometrial Cancer from Benign Endometrial Lesions in Postmenopausal Patients with Endometrial Masses
od: Song YJ, et al.
Izdano: (2023-10-01)

Accuracy of Pre-operative Endometrial Sampling for the Detection of High Grade Endometrial Cancer
od: Uraiwan Khomphaiboonkij, et al.
Izdano: (2015-09-01)

Telomerase and Telomeres in Endometrial Cancer
od: Rafah A. A. Alnafakh, et al.
Izdano: (2019-05-01)

Comparison of Oncological and Surgical Outcomes of Robot-Assisted, Laparoscopic Modified Radical Hysterectomy and Laparotomy for Endometrial Cancer
od: Masako Ishikawa, et al.
Izdano: (2024-02-01)

Chromatin and the DNA damage response: The cancer connection
od: Martijn S. Luijsterburg, et al.
Izdano: (2011-08-01)

Psychometric validation of the Functional Assessment of Cancer Therapy‐Endometrial among endometrial cancer patients
od: Sooyeon Kim, et al.
Izdano: (2024-03-01)

Model Predicting the Risk of Endometrial Hyperplasia Developing into Endometrial Cancer
od: Su J, et al.
Izdano: (2024-09-01)

SENTINEL LYMPH NODES IN ENDOMETRIAL CANCER
od: A. I. Berishvili, et al.
Izdano: (2017-06-01)

Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
od: Haley A. Moss, et al.
Izdano: (2014-12-01)

Axin2+ endometrial stem cells: the source of endometrial regeneration and cancer
od: Shafiq M. Syed, et al.
Izdano: (2020-05-01)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
od: Dan Kuai, et al.
Izdano: (2023-07-01)

A multiomics comparison between endometrial cancer and serous ovarian cancer
od: Hui Zhong, et al.
Izdano: (2020-01-01)